HSPG2 and cyclic hematopoiesis: Treatment of OA-CH with the specific PLC-ß inhibitor U73122 in combination with SP and αCGRP lead to an inhibition of ERK phosphorylation (Figures 7E, F), similar to the effect seen in non-OA-CH.